Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hemorrhagic Shock, Trauma, Exsanguinating Hemorrhage or Shock; Traumatic
and you are
over 15
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.

Provided treatments

  • Device: ResQFoam
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02880163. The sponsor of the trial is Arsenal Medical, Inc. and it is looking for 40 volunteers for the current phase.
Official trial title:
Reducing Exsanguination Via In-Vivo Expandable Foam